<DOC>
	<DOC>NCT01784692</DOC>
	<brief_summary>This will be a small study aimed at determining the effects of oral Immulina consumption on the immune system in elderly individuals.</brief_summary>
	<brief_title>Pilot Study to Evaluate Immunopotentiating Effects of Immulina in Elderly Individuals</brief_title>
	<detailed_description />
	<criteria>Age 60 and older; Generally otherwise healthy for age and not taking medications/supplements that could be expected to affect stress responses and/or impact immune parameters (example systemic steroids, beta blockers, antidepressants, antianxiety drugs, Echinacea supplements, ginseng supplements or Spirulina supplements). Inability to comprehend and speak English; Any history of major psychological or psychiatric illness (example dementia, psychotic disorder, acute mania, current substance abuse) that may limit participant cooperation or compromise the integrity of selfreported clinical or psychological data; Presence of a confounding underlying systemic illness which could interfere with immunological profiles (example severe cardiovascular, pulmonary, hepatic, gastrointestinal, renal, neurological, musculoskeletal endocrine , or metabolic systems; other gross physical impairments; or any history of significant convulsive disorder). Specifically, patients with congestive heart failure, recent viral or bacterial illness in the past 3 weeks, chronic kidney disease, thyroid disorder, autoimmune disease will be excluded.</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Immulina</keyword>
	<keyword>Elderly</keyword>
	<keyword>Immune</keyword>
</DOC>